(Q33455377)

26 July 2017

title

Large thrombotic strokes in hemolytic-uremic syndrome (English)

1 reference

hemolytic-uremic syndrome

26 July 2017

main subject

1 reference

Trevathan E

1

1 reference

26 July 2017

Dooling EC

series ordinal

2

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 December 1987

1 reference

The Journal of Pediatrics

26 July 2017

published in

1 reference

26 July 2017

volume

111

1 reference

26 July 2017

issue

6 Pt 1

1 reference

26 July 2017

page(s)

863-866

1 reference

CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

Recovery from prolonged coma in hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

Neurological involvement in hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

Lacunar strokes and infarcts: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

Cranial CT in the haemolytic uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

Stroke in a patient with hemolytic-uremic syndrome with a good outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

Hemorrhagic cerebral infarction in the hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

Transcranial Doppler in cerebrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

Therapy of Ischemic Cerebral Vascular Disease Due to Atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

Therapy of ischemic cerebral vascular disease due to atherothrombosis. (2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

Thrombolytic Therapy in Haemolytic-Uraemic Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

The hemolytic-uremic syndrome: experience at a center in the Midwest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

Heparin therapy in the hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980207-X

10.1016/S0022-3476(87)80207-X

7 January 2021

Identifiers

DOI

1 reference

release_qsfgpve65ngdbhgqz74cvix4mi

26 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qsfgpve65ngdbhgqz74cvix4mi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference